NCT02494700

Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2015-07-06Est. Completion: 2027-06-30

Enrollment target: 50 participants

Locations

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatme…

Birmingham, United StatesEst. completion Apr 28, 2031

Lymphoplasmacytic LymphomaWaldenstrom Macroglobulinemia

This phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab or zanubrut…

Tucson, United StatesEst. completion Mar 31, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.